TCRX (TScan) Pangali Forward P/E
The battle for medical leadership in T-cell therapy is driving growth, as reflected by the P/E forward valuation of TScan Therapeutics (TCRX) on this GURU.Markets platform chart, where 0.00 shows the current value of the metric. The business foundation is the TargetScan technology for creating personalized cancer drugs; however, the financial stability of TScan Therapeutics (TCRX) depends on test results and new investments.
Ringkesan rincian data analitis TScan (TCRX)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- informasi kapitalisasi buku:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal TScan Therapeutics|TCRX - Kewajiban jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas TScan Therapeutics|TCRX - Tanggungan utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku TScan Therapeutics Inc|TCRX - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan TScan Therapeutics|Rasio cepet tscan.com
- rincian asil keuangan lan kelipatan valuasi:
TCRX - Bathi resik|Bathi sing dikarepake TScan Therapeutics|TCRX - Pangali rega marang bathi|Prakiraan rega marang bathi TScan Therapeutics|TCRX - Koefisien bali modal nimbang wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan TScan Therapeutics Inc|TCRX - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi resik saben saham (EPS TTM) TScan Therapeutics|TCRX - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan tscan.com|TCRX - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep TScan Therapeutics
Ringkesan analisis perusahaan:TCRX TScan Therapeutics, Inc.
The development of personalized T-cell therapies at TScan Therapeutics (TCRX) requires colossal investments, making the company's forward P/E ratio a key indicator of capitalization relative to projected earnings. This metric daily compares the market value of shares with expected income, allowing investors to assess the maturation rate of the business model and confirm the fundamental stability of assets amidst infrequent reporting.
Pesaing utama
Prakiraan rega marang bathi ONC (BeiGene)|HALO (Halozyme Therapeutics, Inc.) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E RVMD (RevMed)|AAPG - Prakiraan rega marang bathi|CGON: Prakiraan rega marang bathi|URGN - Pangali Forward P/E|Bicara Therapeutics (BCAX) - Rega marang bathi mangsa ngarep|Personalis Inc - Pangali mangsa ngarep rega marang bathi|ERAS (Erasca Corp) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Delcath Corp DCTH|Prakiraan rega marang bathi YMAB (Y-mAbs Therapeutics)|Rasio kapitalisasi marang bathi mangsa ngarep AURA|Rega marang bathi mangsa ngarep Candel Therapeutics, Inc. CADL|Kapitalisasi marang proyeksi bathi Accuray Inc (ARAY)|SELLAS Life Sciences Group Inc. - Pangali Forward P/E|Actuate Therapeutics Inc (ACTU) - Prakiraan rega marang bathi|CTOR: Pangali Forward P/E|TuHURA Biosciences (HURA) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Protara Therapeutics, Inc.|Rasio rega marang bathi mangsa ngarep FATE (Fate Therapeutics Inc)|Prakiraan rega marang bathi WHWK (Aadi Bioscience Inc)|CSBR (championsoncology.com) - Pangali mangsa ngarep rega marang bathi|XBiotech - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep CVM (CEL-SCI Corp.)|OS Therapies - Pangali Forward P/E|Pangali mangsa ngarep rega marang bathi RADX (radiopharmtheranostics.com)|ARTV: Pangali Forward P/E|Rasio prakiraan rega marang bathi Adlai Nortye (ANL)|Rega marang bathi mangsa ngarep Veru Inc.|TPST: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E XLO|Pangali Forward P/E renovarobio.com (RENB)|Rega marang bathi mangsa ngarep Mural Oncology MURA|KAPA (Kairos Pharma Limited) - Rasio rega marang bathi sing dikarepake|OnKure - Pangali Forward P/E|Rasio prakiraan rega marang bathi CytoMed Therapeutics|CRIS (curis.com) - Prakiraan rega marang bathi|Apollomics (APLM) - Pangali Forward P/E|Prakiraan rega marang bathi THAR|ADVB (Advanced Biomed Corp) - Rasio kapitalisasi marang bathi mangsa ngarep|Pangali Forward P/E GNPX|Kapitalisasi marang proyeksi bathi calidibio.com|Pangali Forward P/E SBFM (Sunshine Biopharma, Inc.)|XBIO - Prakiraan rega marang bathi|SLRX - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi Kitov Pharma PPBT|AONC (aoncology.com) - Prakiraan rega marang bathi|BGNE: Rasio kapitalisasi marang bathi mangsa ngarep|CKPT (Checkpoint Therapeutics, Inc.) - Pangali Forward P/E|Prakiraan rega marang bathi elevationoncology.com (ELEV)|Rega marang bathi mangsa ngarep iCAD, Inc. (ICAD)|IKNA (ikenaoncology.com) - Pangali mangsa ngarep rega marang bathi|Notable Labs, Ltd. - Prakiraan rega marang bathi|VIRX: Rasio rega marang bathi mangsa ngarep|MorphoSys - Pangali Forward P/E|NAYA Biosciences Inc (NAYA) - Prakiraan rega marang bathi|AAPGV: Pangali Forward P/E
